CORBUS PHARMACEUTICALS HOLDI (CRBP:NASDAQ)

$5.38 0.11 (2.0873%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 74

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed CORBUS PHARMACEUTICALS HOLDI (CRBP:NASDAQ) News Sources

Corbus Pharmaceuticals Announces the Appointment of Nishant Saxena as Chief Business Officer and Schedules a Pre-2026 ASCO CRB-701 Data Conference Call

21-05-2026

yahoo.com

Corbus Pharmaceuticals Targets HPV-Linked Head and Neck Cancer With CRB-701 Study

01-06-2026

marketbeat.com

Corbus Pharmaceuticals Announces FDA Clearance to Initiate TEMPO-1 Registrational Study of CRB-701 in Patients with 2L Oropharyngeal Cancer

28-07-2026

yahoo.com

Corbus Pharmaceuticals Announces Last Patient Last Visit in CANYON-1 Study of CRB-913 for the Treatment of Obesity

04-08-2026

yahoo.com

Corbus Pharmaceuticals Reports Q2 2026 Financial Results and Provides a Corporate Update

06-08-2026

yahoo.com

Corbus Pharmaceuticals to Host Conference Call to Discuss Topline Data from CANYON-1 Clinical Trial and the Potential of CRB-913 In Obesity

11-09-2026

yahoo.com

Corbus Pharmaceuticals Announces Positive Topline Data from CANYON-1 Study of Daily Oral CRB-913 for the Treatment of Obesity

14-09-2026

yahoo.com

Corbus Pharmaceuticals Shares Rise 12% After CANYON-1 Obesity Trial Data

14-09-2026

advfn.com

Corbus CRB-913 Delivers 5% Weight Loss in Phase 1b Obesity Study

15-09-2026

marketbeat.com

Corbus Pharmaceuticals Announces First Patient Dosed in TEMPO-1 Registrational Study of CRB-701 in Patients with 2L+ Oropharyngeal Cancer

29-09-2026

yahoo.com

CORBUS PHARMACEUTICALS HOLDI (CRBP:NASDAQ) Sentiment Trend

0 25 50 75 100 61 72 83 82 62 78 80 88 53 83 21-05-2026 01-06-2026 28-07-2026 04-08-2026 06-08-2026 11-09-2026 14-09-2026 15-09-2026 29-09-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

CORBUS PHARMACEUTICALS HOLDI (CRBP:NASDAQ) FAQs

toggle

What is the current price of CORBUS PHARMACEUTICALS HOLDI (CRBP:NASDAQ)?

The current price of CORBUS PHARMACEUTICALS HOLDI (CRBP:NASDAQ) is $5.38.


toggle

CORBUS PHARMACEUTICALS HOLDI (CRBP:NASDAQ) absolute price change since previous trading day?

The absolute price change of CORBUS PHARMACEUTICALS HOLDI (CRBP:NASDAQ) since the previous trading day is $0.11.


toggle

CORBUS PHARMACEUTICALS HOLDI (CRBP:NASDAQ) percentage price change since previous trading day?

The percentage price change of CORBUS PHARMACEUTICALS HOLDI (CRBP:NASDAQ) since the previous trading day is 2.0873%.


toggle

What is the most recent average sentiment score for CORBUS PHARMACEUTICALS HOLDI (CRBP:NASDAQ)?

The most recent average sentiment score for CORBUS PHARMACEUTICALS HOLDI (CRBP:NASDAQ) is 74 out of 100.


toggle

What is the most recent average sentiment for CORBUS PHARMACEUTICALS HOLDI (CRBP:NASDAQ)?

The most recent sentiment for CORBUS PHARMACEUTICALS HOLDI (CRBP:NASDAQ) is .


SEC-8K** Filing Available For CORBUS PHARMACEUTICALS HOLDI (CRBP:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.